ncRNA name
hsa-miR-3646
Specific or universal ncRNAs
Specific ncRNAs
Class
MicroRNA
Biomarker
No
Biomarker application
Upstream regulatory factors
Not available
Downstream target
GSK3Ī²/Ī²-catenin signaling pathway
Cancer name
Breast Cancer
Cancer site
Breast
Treatment type
Chemotherapy
Drug
Docetaxel
Impact of wild-type ncRNA on chemotherapy resistance
Up
Impact of knockdown of ncRNA on chemotherapy resistance
Impact of overexpression of ncRNA on chemotherapy resistance
ncRNA differential expression in
cancer
patients vs. healthy people
Not available
Number of patients
Not available
Male patients
Not available
Female patients
Not available
Age range and number
Not available
PMID
Description
MicroRNA-3646 Contributes to Docetaxel Resistance in Human Breast Cancer Cells by GSK-3Ī²/Ī²-Catenin Signaling Pathway.
Tissue resource
human breast cancer cell lines MDA-MB-231
human breast cancer cell lines MCF-7
Experiment
qRT-PCR
Institute
the Cell Biology of Chinese Academy of Sciences
Country
China
Continent
Asia